File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Microfluidics as an emerging platform for tackling antimicrobial resistance (AMR): A review

TitleMicrofluidics as an emerging platform for tackling antimicrobial resistance (AMR): A review
Authors
KeywordsColorimetry
Minimum inhibitory concentration (MIC)
Antibiotic
Point-of-care
Antimicrobial susceptibility testing (AST)
Lab-on-a-chip
Microfluidics
Antimicrobial resistance (AMR)
Capillary flow
Issue Date2020
Citation
Current Analytical Chemistry, 2020, v. 16, n. 1, p. 41-51 How to Cite?
AbstractBackground: Antimicrobial resistance (AMR) occurs when microbes become resistant to antibiotics causing complications and limited treatment options. AMR is more significant where antibiotics use is excessive or abusive and the strains of bacteria become resistant to antibiotic treatments. Current technologies for bacteria and its resistant strains identification and antimicrobial susceptibility testing (AST) are mostly central-lab based in hospitals, which normally take days to weeks to get results. These tools and procedures are expensive, laborious and skills based. There is an ever-increasing demand for developing point-of-care (POC) diagnostics tools for rapid and near patient AMR testing. Microfluidics, an important and fundamental technique to develop POC devices, has been utilized to tackle AMR in healthcare. This review mainly focuses on the current development in the field of microfluidics for rapid AMR testing. Method: Due to the limitations of conventional AMR techniques, microfluidic-based platforms have been developed for better understandings of bacterial resistance, smart AST and minimum inhibitory concentration (MIC) testing tools and development of new drugs. This review aims to summarize the recent development of AST and MIC testing tools in different formats of microfluidics technology. Results: Various microfluidics devices have been developed to combat AMR. Miniaturization and integration of different tools has been attempted to produce handheld or standalone devices for rapid AMR testing using different formats of microfluidics technology such as active microfluidics, droplet microfluidics, paper microfluidics and capillary-driven microfluidics. Conclusion: Current conventional AMR detection technologies provide time-consuming, costly, labor-intensive and central lab-based solutions, limiting their applications. Microfluidics has been developed for decades and the technology has emerged as a powerful tool for POC diagnostics of antimicrobial resistance in healthcare providing, simple, robust, cost-effective and portable diagnostics. The success has been reported in research articles; however, the potential of microfluidics technology in tackling AMR has not been fully achieved in clinical settings.
Persistent Identifierhttp://hdl.handle.net/10722/303643
ISSN
2021 Impact Factor: 2.374
2020 SCImago Journal Rankings: 0.289
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorHassan, Sammer Ul-
dc.contributor.authorZhang, Xunli-
dc.date.accessioned2021-09-15T08:25:44Z-
dc.date.available2021-09-15T08:25:44Z-
dc.date.issued2020-
dc.identifier.citationCurrent Analytical Chemistry, 2020, v. 16, n. 1, p. 41-51-
dc.identifier.issn1573-4110-
dc.identifier.urihttp://hdl.handle.net/10722/303643-
dc.description.abstractBackground: Antimicrobial resistance (AMR) occurs when microbes become resistant to antibiotics causing complications and limited treatment options. AMR is more significant where antibiotics use is excessive or abusive and the strains of bacteria become resistant to antibiotic treatments. Current technologies for bacteria and its resistant strains identification and antimicrobial susceptibility testing (AST) are mostly central-lab based in hospitals, which normally take days to weeks to get results. These tools and procedures are expensive, laborious and skills based. There is an ever-increasing demand for developing point-of-care (POC) diagnostics tools for rapid and near patient AMR testing. Microfluidics, an important and fundamental technique to develop POC devices, has been utilized to tackle AMR in healthcare. This review mainly focuses on the current development in the field of microfluidics for rapid AMR testing. Method: Due to the limitations of conventional AMR techniques, microfluidic-based platforms have been developed for better understandings of bacterial resistance, smart AST and minimum inhibitory concentration (MIC) testing tools and development of new drugs. This review aims to summarize the recent development of AST and MIC testing tools in different formats of microfluidics technology. Results: Various microfluidics devices have been developed to combat AMR. Miniaturization and integration of different tools has been attempted to produce handheld or standalone devices for rapid AMR testing using different formats of microfluidics technology such as active microfluidics, droplet microfluidics, paper microfluidics and capillary-driven microfluidics. Conclusion: Current conventional AMR detection technologies provide time-consuming, costly, labor-intensive and central lab-based solutions, limiting their applications. Microfluidics has been developed for decades and the technology has emerged as a powerful tool for POC diagnostics of antimicrobial resistance in healthcare providing, simple, robust, cost-effective and portable diagnostics. The success has been reported in research articles; however, the potential of microfluidics technology in tackling AMR has not been fully achieved in clinical settings.-
dc.languageeng-
dc.relation.ispartofCurrent Analytical Chemistry-
dc.subjectColorimetry-
dc.subjectMinimum inhibitory concentration (MIC)-
dc.subjectAntibiotic-
dc.subjectPoint-of-care-
dc.subjectAntimicrobial susceptibility testing (AST)-
dc.subjectLab-on-a-chip-
dc.subjectMicrofluidics-
dc.subjectAntimicrobial resistance (AMR)-
dc.subjectCapillary flow-
dc.titleMicrofluidics as an emerging platform for tackling antimicrobial resistance (AMR): A review-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.2174/1573411015666181224145845-
dc.identifier.scopuseid_2-s2.0-85078436154-
dc.identifier.volume16-
dc.identifier.issue1-
dc.identifier.spage41-
dc.identifier.epage51-
dc.identifier.isiWOS:000506630800004-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats